Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 


SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Tenax Therapeutics : Indian COVID-19 patients die as ventilators run out of oxygen; infections surge

04/21/2021 | 02:07am EDT

* India's daily infections at record

* Delhi hospitals scramble as oxygen supplies run out

* One of three in Delhi tests positive for COVID-19 (Updates death toll, adds details on new curbs imposed by Maharashtra state, directive by German consulate)

SATARA, India, April 21 (Reuters) - At least 24 COVID-19 patients in western India died on Wednesday when the oxygen supply to their ventilators ran out, amid a nationwide shortage of the gas and a surge in infections.

Maharashtra State Health Minister Rajesh Tope confirmed the deaths at a hospital in Nashik city and said the hospital's oxygen supply ran out because a tanker refilling it suffered a leak. Oxygen was running scarce throughout the country.

"The leakage was spotted at the tank supplying oxygen for these patients. The interrupted supply could be linked to the deaths of the patients in the hospital," Tope said.

Hospitals in Delhi, the capital, and elsewhere have warned that their supplies of medical oxygen given to severely ill COVID-19 patients are running low.

Max Healthcare, the largest private sector healthcare provider in Delhi and its suburbs, said some of its hospitals had barely two hours' supply of oxygen.

Television showed images of people with empty oxygen cylinders crowding refilling facilities in the most populous state of Uttar Pradesh, as they scrambled to save stricken relatives in hospital.

The situation was so severe that some people tried to loot an oxygen tanker, forcing authorities to beef up security, according to the health minister of the northern state of Haryana.

India now faces a coronavirus "storm" overwhelming its health system, Prime Minister Narendra Modi said in a national address on Tuesday, adding that authorities were working with states and private firms to deliver oxygen with speed.

Authorities in Maharashtra, which is already under partial lockdown, late on Wednesday ordered additional restrictions on the movement of people within the city and state until May 1 to curb the coronavirus' spread.

The order said all offices, except those providing essential services, must operate with 15% staff. Travel by private vehicles is permitted only for medical emergencies, and only medical workers and government employees may ride the normally popular train system.

India, the world's second-most populous nation reported 295,041 new coronavirus infections on Wednesday - the biggest daily rise reported in any country - stretching its hospitals to breaking point, officials said.

Only the United States had a slightly higher one-day rise of 297,430 cases in January, though its tally has since fallen sharply. India's 2,023 deaths were also its highest in the pandemic.

Adding to the sense of alarm, the Serum Institute of India, which manufactures the AstraZeneca COVID-19 vaccine, said it will not be able to raise its monthly output to 100 million doses from the current 60 million-70 million until July, compared to its previous forecast of late May.

The delay could slow India's immunisation drive, which the government has opened for all adults from next month to try to stem the deadly second wave.


Health experts said India had let its guard down when the virus seemed to be under control during the winter, allowing big gatherings such as weddings and festivals.

Modi is himself facing criticism for addressing packed political rallies for local elections and allowing a religious festival to go ahead where millions gathered.

India has so far administered nearly 130 million doses of vaccine, the most in the world after the United States and China but still small relative to its population of 1.35 billion people.(https://tmsnrt.rs/3tlH6Gq)

Vaccine doses have run short in many states though inoculations are currently restricted to frontline workers and those aged above 45.

Germany on Wednesday warned its citizens in India that the health risk of staying in the country had "considerably" increased due to shortage of beds in hospitals. (Global vaccination tracker: https://graphics.reuters.com/world-coronavirus-tracker-and-maps/vaccination-rollout-and-access/)

(Additional reporting by Neha Arora, Aditya Kalra, Devjyot Ghoshal, Krishna N.Das and Danish Siddiqui in New Delhi, Sachin Ravikumar in Bengaluru; Editing by Sanjeev Miglani and Cynthia Osterman)

© Reuters 2021
Stocks mentioned in the article
ChangeLast1st jan.
ASTRAZENECA PLC -0.36% 8352 Delayed Quote.14.47%
TENAX THERAPEUTICS, INC. -5.42% 1.92 Delayed Quote.3.23%
06/11TENAX THERAPEUTICS, INC.  : Submission of Matters to a Vote of Security Holders ..
06/10TENAX THERAPEUTICS  : Set to Join Russell Microcap® Index
05/17TENAX THERAPEUTICS : Q1 Earnings Snapshot
05/17TENAX THERAPEUTICS  : Earnings Flash (TENX) TENAX THERAPEUTICS Posts Q1 Loss $-1..
05/17TENAX THERAPEUTICS  : Reports First Quarter 2021 Results and Provides Business U..
04/27Medical supplies flow into India as COVID-19 deaths near 200,000
04/21TENAX THERAPEUTICS  : Indian COVID-19 patients die as ventilators run out of oxy..
04/20Oxygen shares, real and imaginary, rally as India battles virus surge
04/09TENAX THERAPEUTICS'  : Levosimendan Drug Candidate Shows Positive Results in Hyp..
04/09MIDDAY REPORT : Wall Street Firmer Midday Amid Producer Prices Spike
More news
Financials (USD)
Sales 2021 - - -
Net income 2021 -33,2 M - -
Net Debt 2021 - - -
P/E ratio 2021 -1,20x
Yield 2021 -
Capitalization 48,4 M 48,4 M -
Capi. / Sales 2021 -
Capi. / Sales 2022 1,94x
Nbr of Employees -
Free-Float 67,0%
Duration : Period :
Tenax Therapeutics, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends TENAX THERAPEUTICS, INC.
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus UNDERPERFORM
Number of Analysts 2
Average target price 4,75 $
Last Close Price 1,92 $
Spread / Highest target 160%
Spread / Average Target 147%
Spread / Lowest Target 134%
EPS Revisions
Managers and Directors
Anthony A. DiTonno Chief Executive Officer & Director
Michael B. Jebsen President & Chief Financial Officer
Gerald T. Proehl Chairman
Stuart Rich Director & Chief Medical Officer
Doug Randall Executive VP-Commercial & Business Operations
Sector and Competitors
1st jan.Capitalization (M$)
MODERNA, INC.90.67%79 980
LONZA GROUP LTD14.63%52 508
CELLTRION, INC.-24.79%32 465
SEAGEN INC.-10.75%28 367